Ultragenyx Pharmaceutical, Inc. RARE
NASDAQ · United States · Health Technology
$14.89-0.14 (-0.93%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.90 | -1.22 | +26.1% | $214.00M | +16.9% | -0.4%$25.02→$24.93 |
| Q1 2026 | 2026-05-05 | -1.54 | -1.46 | -5.5% | — | — | +4.5%$24.81→$25.93 |
| Q4 2025 | 2026-02-12 | -1.29 | -1.17 | -10.3% | — | — | -14.1%$23.88→$20.52 |
| Q3 2025 | 2025-11-04 | -1.81 | -1.21 | -49.6% | — | — | -4.8%$33.47→$31.87 |
| Q2 2025 | 2025-08-05 | -1.17 | -1.32 | +11.4% | — | — | — |
| Q1 2025 | 2025-05-06 | -1.57 | -1.64 | +4.3% | — | — | — |
| Q4 2024 | 2025-02-13 | -1.39 | -1.27 | -9.4% | — | — | — |
| Q3 2024 | 2024-11-05 | -1.40 | -1.47 | +4.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.